Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:12 PM UTC
| NCT Number | NCT06966401 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE3 |
| Target Enrollment | 850 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06966401 is currently recruiting participants. This phase3 study for major depressive disorder is actively seeking new participants at 44 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06966401 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06966401 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.